From genomic insights to clinical hope: Targeting NEU1 in IgA nephropathy
CONCLUSION: This study identifies NEU1 as a promising therapeutic target for IgAN, backed by robust genetic evidence. Future research should explore NEU1's therapeutic potential in diverse populations and clinical scenarios, further establishing its role in IgAN.PMID:38599098 | DOI:10.1016/j.intimp.2024.112051
Source: International Immunopharmacology - Category: Allergy & Immunology Authors: Cong Zhao Mingzhu Zhang Leying Zhao Weiwei Sun Source Type: research
More News: Allergy & Immunology | Genetics | Glomerulonephritis | Influenza | Men | PET Scan | Statistics | Study